Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
Actual shortage: | 8 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26118 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32181 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-01-03 | 2018-03-01 | 34771 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56909 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56912 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-02-15 | 2019-03-01 | 76027 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-08-27 | 2019-10-10 | 92505 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-09-20 | 2019-10-10 | 94473 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-11-05 | 2019-11-12 | 97992 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-01-17 | 2020-02-11 | 103477 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |